Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
To evaluate the immunogenicity and safety of the monovalent pandemic influenza A (H1N1) 2009 (pH1N1) vaccine in HIV-infected Thai children, 2 doses, 28days apart, of non-adjuvant monovalent pH1N1 vaccine (Panenza® by Sanofi Pasteur, 15μg/dose) provided by the National Health Promotion Program of the...
Saved in:
Main Authors: | Phongsamart W., Sirisanthana V., Wittawatmongkol O., Maleesatharn A., Sudjaritruk T., Chearskul P., Aurpibul L., Sirisanthana T., Chokephaibulkit K. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-82455192719&partnerID=40&md5=78078c78735aee2d0fe08d311fee9c6c http://cmuir.cmu.ac.th/handle/6653943832/3710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
by: Wanatpreeya Phongsamart, et al.
Published: (2018) -
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
by: Wanatpreeya Phongsamart, et al.
Published: (2018) -
High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand
by: Sasisopin Kiertiburanakul, et al.
Published: (2018) -
Comparison of the immunogenicity of a monovalent influenza A/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations
by: S. P. Watcharananan, et al.
Published: (2018) -
Safety and immunogenicity of influenza A H1N1 vaccines
by: Lu, W., et al.
Published: (2011)